TABLE 3

Markers of cardiovascular risks and oxidative stress at admission and resolution of hyperglycemic crisis

Lean DKA
Obese DKA
Obese hyperglycemia
Lean controlObese control
AdmissionResolutionAdmissionResolutionAdmissionResolution
CRP (mg/l)51 ± 328 ± 1*59 ± 1334 ± 9*28 ± 613 ± 3*1 ± 0.2*2 ± 0.4*
Homocysteine (μmol/l)18.8 ± 0.814.8 ± 0.7*23.6 ± 3.621.6 ± 2.814.8 ± 1.612.4 ± 1.2*7.2 ± 0.4*8.8 ± 1.2*
FFA (mmol/l)1.6 ± 0.10.6 ± 0.1*1.4 ± 0.10.7 ± 0.1*1.2 ± 0.20.8 ± 0.1*0.5 ± 0.1*0.7 ± 0.1*
DCF (μmol/l)8.6 ± 0.83.7 ± 0.5*8.9 ± 1.24.1 ± 0.7*7.8 ± 0.63.8 ± 0.5*2.3 ± 0.4*3.1 ± 0.6*
TBA (μmol/l)3.8 ± 0.71.3 ± 0.4*4.0 ± 0.61.6 ± 0.2*3.3 ± 0.51.5 ± 0.4*0.8 ± 0.1*0.9 ± 0.1*
PAI-1 (ng/ml)42.1 ± 12.24.2 ± 2.1*40.4 ± 12.413.0 ± 3.4*35.4 ± 9.37.3 ± 2.4*1.4 ± 0.2*2.5 ± 0.4*
  • Data are means ± SE.

  • *

    * P < 0.01 vs. lean DKA on admission;

  • P < 0.05 vs. admission value of each group.